Inventor
HELFTENBEIN GERD
DE15 patents
⚠️ This page may combine multiple inventors who share the name “HELFTENBEIN GERD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIONTECH AG
7 patentsUS9533043B2Jan 3, 2017
Identification of surface-associated antigens for tumor diagnosis and therapy
BIONTECH AG7 citations83
US9267177B2Feb 23, 2016
Identification of tumor-associated cell surface antigens for diagnosis and therapy
BIONTECH AG6 citations83
US9194004B2Nov 24, 2015
Identification of surface-associated antigens for tumor diagnosis and therapy
BIONTECH AG6 citations82
US10724103B2Jul 28, 2020
Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapy
BIONTECH AG1 citations71
US10302647B2May 28, 2019
Identification of surface-associated antigens for tumor diagnosis and therapy
BIONTECH AG0 citations51
US9139880B2Sep 22, 2015
Identification of tumor-associated cell surface antigens for diagnosis and therapy
BIONTECH AG0 citations51
US9910043B2Mar 6, 2018
Identification of tumor-associated cell surface antigens for diagnosis and therapy
BIONTECH AG0 citations50
GANYMED PHARMACEUTICALS AG
5 patentsUS7785801B2Aug 31, 2010
Identification of surface-associated antigens for tumor diagnosis and therapy
GANYMED PHARMACEUTICALS AG14 citations91
US7875424B2Jan 25, 2011
Identification of tumour-associated cell surface antigens for diagnosis and therapy
GANYMED PHARMACEUTICALS AG1 citations60
US11473085B2Oct 18, 2022
Methods and compositions for diagnosis and treatment of cancer
GANYMED PHARMACEUTICALS AG1 citations57
US10036753B2Jul 31, 2018
Identification of surface-associated antigens for tumor diagnosis and therapy
GANYMED PHARMACEUTICALS AG0 citations51
US9733251B2Aug 15, 2017
Identification of tumour-associated cell surface antigens for diagnosis and therapy
GANYMED PHARMACEUTICALS AG0 citations51